The objective of this study was to identify apoptotic bodies and p53 positi
vity in inverting papilloma lesions to study these two as biomarkers in pre
malignant lesions. Archival specimens of 15 patients with inverting papillo
ma between the years 1992 and 1995 were retrieved. In situ end labeling tec
hnique was used to identify apoptotic bodies. Immunohistochemistry was used
to detect p53 in the same specimens. The clinical course was evaluated con
ducting a retrospective chart review in these patients. Compared to normal
epithelium, inverting papilloma lesions had a greater proportion of apoptot
ic bodies, which was nearly statistically significant (average 0.506/100 ce
lls for inverting papilloma compared with 0.1/100 cells for the normal surr
ounding, tissue). Four cases of inverting papilloma were p53 positive. Ther
e was, however, no association between p53 positive staining and the apopto
tic rate. The minimum follow-up for patients was 2 years. All had a uniform
ly good clinical outcome with only one patient who was p53 positive showing
concurrent squamous cell carcinoma. We concluded that inverting papilloma
contained a higher average number of apoptotic bodies compared with normal
surrounding sinonasal tissue. This showed a trend toward a positive between
the apoptotic rate and premalignancy, suggesting both increased cellular p
roliferation and increased cell death may occur in such lesions. In this st
udy p53 did not show a positive association with the apoptotic rate, sugges
ting that p53 may not be directly involved in the apoptotic regulatory path
way in inverting papillomas.